🇺🇸 FDA
Patent

US 11479530

Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment

granted A61KA61K31/40A61K45/06

Quick answer

US patent 11479530 (Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment) held by The Regents of the University of California expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/40, A61K45/06, A61P, A61P35/00